Lemke JR, Eoli A, Krey I, Popp B, Strehlow V, Wittekind DA, Vuorinen AL, Aldhalaan HM, Baer S, de Saint Martin A, Hammer TB, Herman I, Hornemann F, Ingebrigtsen T, Lederer D, Lesca G, Marafie D, Mathot M, Rosenfeld JA, Møller RS, Schelhaas HJ, Stillman C, Orsini A, Patel AD, Piard J et al. (2025)
GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy
Mol Psychiatry (in press)
DOI 10.1038/s41380-025-03279-4, PubMed 41087560

Sudmann TM, Jeber AK, Brækhus A, Klungsøyr O, Rowe FJ, Jørstad ØK (2025)
The impact of different spectacle designs on the European visual field requirements for driving
J Optom, 100582 (in press)
DOI 10.1016/j.optom.2025.100582, PubMed 41087270

Kirsebom BE, Nilsson J, Vromen E, Arnesen PM, Bjørnerud A, Brinkmalm A, Bråthen G, Grøntvedt GR, Jarholm J, Nordengen K, Pålhaugen L, Selnes P, Siafarikas N, Skogseth RE, Tecelão S, Waterloo K, You P, Zetterberg H, Aarsland D, Tijms B, Visser PJ, Blennow K, Fladby T (2025)
Cerebrospinal fluid markers link to synaptic plasticity responses and Alzheimer's disease genetic pathways
Mol Neurodegener, 20 (1), 107
DOI 10.1186/s13024-025-00899-w, PubMed 41084010